About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT05808621

Muscle Oxygenation in Chronic Obstructive Pulmonary Disease

The aim of our study is to examine the Peripheral Muscle Oxygenations at rest and in motion on the 2nd day of hospitalized patients and before discharge in Severe Acute Exacerbation of Chronic Obstruc...

Lead sponsor: Bandırma Onyedi Eylül University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Bandırma Onyedi Eylül University

Age

40 - 80 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Being a COPD patient hospitalized with Severe Acute Exacerbation
•be between 40-80 years old
•Having a Body Mass Index below 35

Exclusion Criteria

•Patients who do not want to participate in the study
•Patients requiring intensive care follow-up during their hospitalization Arthritis, neurological disease, deep vein thrombosis, peripheral arterial disease, muscle weakness, broken etc. patients with the condition
•Extensive parenchyma such as malignancy, pulmonary embolism, vasculitis, collagen tissue diseases, interstitial fibrosis, severe pneumonia patients with damage
•Patients with severe dyspnea and hemodynamic instability who cannot perform the sit-up test

Related studies

CLEAR Model for Predicting Ventilatory Liberation in Severe COPD

NCT07579052 · Chronic Obstructive Pulmonary Disease

Pulmonary Rehabilitation for Rural Patients With COPD

NCT06847061 · Chronic Obstructive Pulmonary Disease (COPD

RECRUITINGPhase 2

Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD

NCT05061368 · Chronic Obstructive Pulmonary Disease

RECRUITINGPhase 1/2

Feasibility of Semaglutide in Advanced Lung Disease

NCT05746039 · Obesity, Interstitial Lung Disease, and more

RECRUITINGPhase 3

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

NCT07190209 · Chronic Obstructive Pulmonary Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 13, 2025Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment41

Start dateMar 2023

Last updatedMar 13, 2025

Condition

Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease Exacerbation Muscle Oxygenation

Locations shown

Bandırma Onyedi Eylül University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation

Balıkesir

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 13, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions